US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
US20030083461A1
(en)
|
1997-06-16 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
JP4855577B2
(ja)
|
1998-06-01 |
2012-01-18 |
アジェンシス,インコーポレイテッド |
ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
CA2359132A1
(en)
|
1999-01-15 |
2000-07-20 |
Roxanne D. Duan |
Bone marrow-specific protein
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
ATE478145T1
(de)
*
|
1999-06-02 |
2010-09-15 |
Genentech Inc |
Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
|
US20030204052A1
(en)
*
|
2000-10-04 |
2003-10-30 |
Herrmann John L. |
Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
|
WO2001014552A1
(fr)
*
|
1999-08-19 |
2001-03-01 |
Kurokawa, Kiyoshi |
Proteine meg-1
|
US7790861B2
(en)
*
|
1999-09-24 |
2010-09-07 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
US20020042062A1
(en)
|
1999-09-24 |
2002-04-11 |
Mark Stearns |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
AU1472701A
(en)
*
|
1999-11-12 |
2001-06-06 |
Human Genome Sciences, Inc. |
28 human secreted proteins
|
AU2288601A
(en)
|
1999-12-23 |
2001-07-03 |
Millennium Pharmaceuticals, Inc. |
P2Y12 receptor
|
WO2003048326A2
(en)
*
|
2001-12-03 |
2003-06-12 |
Nuvelo, Inc. |
Methods and materials relating to novel polypeptides and polynucleotides
|
CA2399860A1
(en)
|
2000-02-11 |
2001-08-16 |
Glycozym Aps |
Udp-galactose: .beta.-d-galactose-r 4-.alpha.-d-galactosyltransferase, .alpha.4gal-t1
|
JP4342069B2
(ja)
*
|
2000-02-14 |
2009-10-14 |
生化学工業株式会社 |
α1,4−ガラクトース転移酵素およびそれをコードするDNA
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1273657A4
(de)
*
|
2000-03-24 |
2005-04-06 |
Takeda Pharmaceutical |
Neues protein, verfahren zu dessen herstellung und dessen verwendung
|
CA2405104A1
(en)
*
|
2000-04-05 |
2001-10-18 |
Kirin Beer Kabushiki Kaisha |
Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
|
WO2001079466A2
(en)
*
|
2000-04-18 |
2001-10-25 |
Bayer Aktiengesellschaft |
Regulation of human epithin-like serine protease
|
AU2001257407A1
(en)
*
|
2000-04-26 |
2001-11-07 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
US20030092035A1
(en)
|
2000-05-04 |
2003-05-15 |
Anderson David J. |
Pain signaling molecules
|
US7510845B2
(en)
|
2000-05-04 |
2009-03-31 |
California Institute Of Technology |
Assay employing G protein-coupled receptor expressed in dorsal root ganglia
|
WO2001085935A2
(en)
*
|
2000-05-09 |
2001-11-15 |
Bayer Aktiengesellschaft |
Endothelial differentiation gene 6-like g protein coupled receptor
|
WO2001092494A2
(en)
*
|
2000-05-26 |
2001-12-06 |
Millennium Pharmaceuticals, Inc. |
50250, a human lipase and uses thereof
|
AU2001268570A1
(en)
*
|
2000-06-16 |
2001-12-24 |
Millennium Pharmaceuticals, Inc. |
33358, a novel human ankyrin family member and uses thereof
|
WO2001098354A2
(en)
*
|
2000-06-21 |
2001-12-27 |
Incyte Genomics, Inc. |
Human receptors
|
WO2002000861A2
(en)
*
|
2000-06-26 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
Human beta-ketoacyl synthase (46619) and uses thereof
|
AU2001281933A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Ingenium Pharmaceuticals Ag |
Human g protein-coupled receptor igpcr17, and uses therof
|
WO2002006312A2
(en)
*
|
2000-07-13 |
2002-01-24 |
Novartis Ag |
Disease-associated gene
|
WO2002008392A2
(en)
*
|
2000-07-25 |
2002-01-31 |
Bayer Aktiengesellschaft |
Regulation of human matriptase-like serine protease
|
WO2003024276A1
(en)
*
|
2000-08-02 |
2003-03-27 |
Millennium Pharmaceuticals,Inc. |
A human gtp-releasing factor family member (15368) and uses therefor
|
EP1307557A2
(de)
|
2000-08-02 |
2003-05-07 |
The Johns Hopkins University |
Expressionsmuster von endothelzellen
|
WO2002012325A2
(en)
*
|
2000-08-04 |
2002-02-14 |
Ludwig Institute For Cancer Research |
Suppressor gene
|
EP1688496A3
(de)
*
|
2000-08-14 |
2006-08-16 |
Actimis Pharmaceuticals, Inc., |
Regulierung des menschlichen P2Y1-ähnlichen G-Protein gekoppelten Rezeptors
|
US20040038879A1
(en)
*
|
2000-08-14 |
2004-02-26 |
Shyam Ramakrishnan |
Regulation of human p2y1-like g protein-coupled receptor
|
AU2001284902A1
(en)
*
|
2000-08-15 |
2002-02-25 |
Zymogenetics Inc. |
Human adenosine deaminase
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
US20030166300A1
(en)
*
|
2000-08-30 |
2003-09-04 |
Tang Y. Tom |
Growth-related inflammatory and immune response protein
|
WO2002018552A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
EP1317527A2
(de)
*
|
2000-09-15 |
2003-06-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Zell verbundene gene welche im onkogenese eine rolle spielen, produkten von diese gene und deren therapeutische und diagnostische verwendung
|
US7754435B2
(en)
*
|
2000-09-21 |
2010-07-13 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
AU2001297794A1
(en)
|
2000-10-19 |
2002-12-03 |
Millenium Pharmaceuticals, Inc. |
Methods and compositions of human proteins and uses thereof.
|
CA2427800A1
(en)
|
2000-11-03 |
2002-05-10 |
The Regents Of The University Of California |
Prokineticin polypeptides, related compositions and methods
|
WO2002074960A2
(en)
*
|
2000-11-08 |
2002-09-26 |
Millennium Pharmaceuticals, Inc. |
38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
|
WO2002038743A2
(en)
*
|
2000-11-09 |
2002-05-16 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
WO2002038732A2
(en)
*
|
2000-11-09 |
2002-05-16 |
University Of Virginia Patent Foundation |
Human testis specific serine/threonine kinase
|
US7312086B2
(en)
|
2000-12-07 |
2007-12-25 |
Bristol-Myers Squibb Company |
Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
|
JP2005508600A
(ja)
*
|
2000-12-21 |
2005-04-07 |
インサイト・ゲノミックス・インコーポレイテッド |
核酸関連タンパク質
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US20030148920A1
(en)
*
|
2000-12-27 |
2003-08-07 |
Steven Rosen |
Sulfatases and methods of use thereof
|
WO2002053719A2
(en)
*
|
2001-01-04 |
2002-07-11 |
Incyte Genomics, Inc. |
Cytoskeleton-associated proteins
|
US20040126759A1
(en)
*
|
2001-01-05 |
2004-07-01 |
Baughn Mariah R. |
Molecules for disease detection and treatment
|
US6319679B1
(en)
*
|
2001-01-26 |
2001-11-20 |
Board Of Regents, The University Of Texas System |
PAS kinase
|
US20020115136A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
WO2002064777A2
(de)
*
|
2001-02-14 |
2002-08-22 |
Axaron Bioscience Ag |
Protein 7b6 und 11b4 und zugrundeliegende dna-sequenzen
|
AU2002258520A1
(en)
*
|
2001-03-16 |
2002-10-03 |
Incyte Genomics, Inc. |
Nucleic acid-associated proteins
|
US20030044813A1
(en)
*
|
2001-03-30 |
2003-03-06 |
Old Lloyd J. |
Cancer-testis antigens
|
US20020146795A1
(en)
*
|
2001-04-02 |
2002-10-10 |
Shiaoping Zhu |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
EP2280030A3
(de)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nukleinsäuren und zugehörige Proteine für die Behandlung und den Nachweis von Krebs
|
US7927597B2
(en)
*
|
2001-04-10 |
2011-04-19 |
Agensys, Inc. |
Methods to inhibit cell growth
|
US6962811B2
(en)
|
2001-05-09 |
2005-11-08 |
Millennium Pharmaceuticals, Inc. |
14715, a human fringe family member nucleic acids and uses therefor
|
EP1403368B1
(de)
|
2001-05-29 |
2010-09-01 |
Human Cell Systems, Inc. |
Testikulärer carnitintransporter und sein gen
|
JP2005501528A
(ja)
|
2001-06-05 |
2005-01-20 |
エクセリクシス・インコーポレイテッド |
p53経路のモディファイヤーとしてのGFATsおよび使用方法
|
CA2633171C
(en)
*
|
2001-06-20 |
2012-11-20 |
Genentech, Inc. |
Antibodies against tumor-associated antigenic target (tat) polypeptides
|
AU2002319261A1
(en)
*
|
2001-06-25 |
2003-01-08 |
Bayer Aktiengesellschaft |
Regulation of human serine/threonine protein kinase nek3
|
EP2287186B1
(de)
*
|
2001-09-06 |
2014-12-31 |
Agensys, Inc. |
Nucleinsäure und entsprechendes Protein, STEAP-1, bei der Behandlung und zum Nachweis von Krebs
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
ATE346305T1
(de)
*
|
2001-09-24 |
2006-12-15 |
Gruenenthal Gmbh |
Screeningverfahren für verschiedene indikationen mit bnpi und/oder dnpi
|
US7265214B2
(en)
|
2001-10-19 |
2007-09-04 |
Rigel Pharmaceuticals, Inc. |
Germinal center kinase proteins, compositions and methods of use
|
EP1512007A4
(de)
*
|
2001-10-29 |
2005-08-17 |
Millennium Pharm Inc |
32235, ein mitglied der menschlichen aminotransferasefamilie, und verwendungen dafür
|
WO2003038128A1
(en)
*
|
2001-10-31 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for the treatment and diagnosis of pain disorders using 57749
|
JP2005508633A
(ja)
*
|
2001-10-31 |
2005-04-07 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
32616を用いる腫瘍形成障害および脈管形成障害の処置法および診断法
|
ATE364690T1
(de)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
Posh nukleinsäure, polypeptide und darauf bezogene verfahren
|
EP1450852B1
(de)
*
|
2001-12-04 |
2007-01-17 |
DeveloGen Aktiengesellschaft |
Ptp10d nukleinsäuren und peptide in der regulation von energie-homeostase
|
US20060051852A1
(en)
*
|
2001-12-12 |
2006-03-09 |
Smith Thomas M |
Apyrase polypeptides and nucleic acids encoding same
|
ES2337989T3
(es)
*
|
2001-12-18 |
2010-05-03 |
Endocube Sas |
Nuevas proteinas asociadas a la muerte de la familia thap y rutas par4 relacionadas implicadas en el control de la apoptosis.
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
AU2003244347A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Takeda Chemical Industries, Ltd. |
Angiogenesis inhibitors
|
GB0205112D0
(en)
*
|
2002-03-05 |
2002-04-17 |
Pantherix Ltd |
Enzyme
|
JP4176022B2
(ja)
|
2002-03-11 |
2008-11-05 |
独立行政法人科学技術振興機構 |
実用的キラルジルコニウム触媒
|
DE10212397A1
(de)
|
2002-03-20 |
2003-10-16 |
Universitaetsklinikum Freiburg |
Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie
|
JPWO2003086462A1
(ja)
*
|
2002-03-29 |
2005-08-18 |
セレスター・レキシコ・サイエンシズ株式会社 |
c−Junリン酸化阻害剤
|
AU2002313900A1
(en)
*
|
2002-04-01 |
2003-10-13 |
Info Genes Co., Ltd. |
Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
|
AU2003234274A1
(en)
|
2002-04-26 |
2003-11-10 |
California Institute Of Technology |
D1-1 nucleic acids, polypeptides and related methods
|
US7622443B2
(en)
|
2002-04-26 |
2009-11-24 |
California Institute Of Technology |
Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
|
DE10222845A1
(de)
*
|
2002-05-23 |
2003-12-04 |
Dresden Arzneimittel |
Klonierung, Expression und Charakterisierung der Gesamtsequenz von Phosphodiesterase 8B
|
JP4416650B2
(ja)
*
|
2002-06-28 |
2010-02-17 |
イムクローン・リミテッド・ライアビリティ・カンパニー |
新規なポリヌクレオチドおよびポリペプチド配列ならびにその使用
|
AU2003260312A1
(en)
*
|
2002-07-19 |
2004-02-09 |
Cellzome Ag |
Protein complexes of the TIP60 transcriptional activator protein
|
US7135556B2
(en)
|
2002-07-19 |
2006-11-14 |
Schering Corporation |
NPC1L1 (NPC3) and methods of use thereof
|
JP2004290170A
(ja)
*
|
2002-08-02 |
2004-10-21 |
Takeda Chem Ind Ltd |
疾患関連遺伝子の用途
|
TW200413725A
(en)
*
|
2002-09-30 |
2004-08-01 |
Oncotherapy Science Inc |
Method for diagnosing non-small cell lung cancers
|
US7056685B1
(en)
|
2002-11-05 |
2006-06-06 |
Amgen Inc. |
Receptor ligands and methods of modulating receptors
|
WO2004046342A2
(en)
*
|
2002-11-20 |
2004-06-03 |
Biogen Idec Inc. |
Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas
|
JP2007527193A
(ja)
*
|
2002-12-10 |
2007-09-27 |
アンドキューブ ソシエタ パー アクシオン シンプリフィー |
ケモカインに対する核受容体としてのthapタンパク質と、転写調節、細胞増殖、および細胞分化におけるその役割
|
JP4140951B2
(ja)
*
|
2002-12-18 |
2008-08-27 |
独立行政法人科学技術振興機構 |
転写制御因子zhx3
|
AU2003242352A1
(en)
|
2002-12-29 |
2004-07-29 |
Center For Advanced Science And Technology Incubation, Ltd. |
Adiponectin receptor and gene coding for the same
|
WO2004065551A2
(en)
*
|
2003-01-21 |
2004-08-05 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof
|
ES2428892T3
(es)
|
2003-02-03 |
2013-11-12 |
Japan Science And Technology Agency |
Regeneración y neogénesis de célula visual de la retina con el gen Otx2
|
JP2008500009A
(ja)
*
|
2003-03-03 |
2008-01-10 |
ジェネンテック・インコーポレーテッド |
全身性エリテマトーデスの治療のための組成物と方法
|
AU2004235755A1
(en)
*
|
2003-04-30 |
2004-11-18 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 109P1D4 useful in treatment and detection of cancer
|
WO2004104218A1
(en)
*
|
2003-05-23 |
2004-12-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1)
|
WO2005023855A2
(en)
*
|
2003-09-10 |
2005-03-17 |
Friedrich-Alexander-Uni- Versitatet Erlangen- Nuernberg |
K203 gene and protein
|
WO2005030953A1
(ja)
*
|
2003-09-30 |
2005-04-07 |
Daiichi Pharmaceutical Co., Ltd. |
テトラヒドロ葉酸合成酵素遺伝子
|
WO2005059504A2
(en)
*
|
2003-12-12 |
2005-06-30 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
|
MXPA06008124A
(es)
|
2004-01-16 |
2007-01-26 |
Merck & Co Inc |
Npc1l1 (npc3) y metodos para identificar ligandos del mismo.
|
CA2555675A1
(en)
*
|
2004-02-10 |
2005-08-25 |
Trustees Of Dartmouth College |
Nicotinamide riboside kinase compositions and methods for using the same
|
US8010189B2
(en)
|
2004-02-20 |
2011-08-30 |
Brainsgate Ltd. |
SPG stimulation for treating complications of subarachnoid hemorrhage
|
US9233245B2
(en)
|
2004-02-20 |
2016-01-12 |
Brainsgate Ltd. |
SPG stimulation
|
US8055347B2
(en)
|
2005-08-19 |
2011-11-08 |
Brainsgate Ltd. |
Stimulation for treating brain events and other conditions
|
AU2005223847A1
(en)
|
2004-03-19 |
2005-09-29 |
Yale University |
Detection, isolation and uses of renalase (Monoamine Oxidase C)
|
DE602005014354D1
(de)
*
|
2004-03-30 |
2009-06-18 |
Nsgene As |
Therapeutische verwendung des wachstumsfaktors nsg33
|
US20050222040A1
(en)
*
|
2004-04-05 |
2005-10-06 |
Blm Group, Inc. |
Vertebrate peptide modulators of lipid metabolism
|
BRPI0418766B8
(pt)
|
2004-04-22 |
2021-05-25 |
Agensys Inc |
anticorpo ou seu fragmento, vetor, composição farmacêutica, ensaio e método para detectar a presença de proteína steap-1, bem como método para distribuir um agente citotóxico ou um agente de diagnóstico
|
MX2007001221A
(es)
|
2004-08-04 |
2007-03-23 |
Amgen Inc |
Anticuerpos para proteina dickkopf-1 (dkk-1).
|
WO2006069592A2
(en)
*
|
2004-12-31 |
2006-07-06 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Method for diagnosing an/or predicting preeclampsia and/or related disorders
|
FI20050011A
(fi)
*
|
2005-01-05 |
2006-07-06 |
Jurilab Ltd Oy |
Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
|
WO2006074914A2
(en)
*
|
2005-01-13 |
2006-07-20 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Human rna helicase and therapeutic uses thereof
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
CA2630085A1
(en)
|
2005-11-21 |
2007-05-24 |
Yale University |
Methods of regulating renalase (monoamine oxidase c)
|
US9206242B2
(en)
*
|
2005-11-22 |
2015-12-08 |
National University Corporation Nagoya University |
Application of actin-binding protein to disease associated with cell motility
|
US7910698B2
(en)
|
2006-02-24 |
2011-03-22 |
Schering Corporation |
NPC1L1 orthologues
|
EP2061814B1
(de)
|
2006-10-27 |
2012-06-06 |
Genentech, Inc. |
Antikörper und immunkonjugate sowie ihre verwendungen
|
WO2008136541A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Snu R&Db Foundation |
Angiogenesis inhibitor comprising meteorin as an active ingredient
|
HUE027154T2
(en)
|
2007-07-02 |
2016-08-29 |
Oncomed Pharm Inc |
Preparations and procedures for the treatment and diagnosis of cancer
|
EP2170374A2
(de)
*
|
2007-07-03 |
2010-04-07 |
Andreas Reichert |
Verfahren zur behandlung von erkrankungen im zusammenhang mit mitochondriendysfunktion
|
EP2178551A4
(de)
*
|
2007-07-24 |
2010-07-21 |
Sanare Invest As |
Neuartige polypeptide mit antitumorwirkung
|
CN101910196A
(zh)
|
2007-12-28 |
2010-12-08 |
诺沃-诺迪斯克有限公司 |
Ddr1-介导的从它们的祖细胞向胰腺内分泌细胞的细胞纯化
|
EP2195013B1
(de)
|
2008-07-24 |
2011-11-02 |
NsGene A/S |
Therapeutische verwendung eines wachstumsfaktors, metrnl
|
DK3255146T3
(da)
|
2009-03-16 |
2019-08-19 |
Pangu Biopharma Ltd |
Præparater og fremgangsmåder omfattende histidyl-tRNA-synthetasesplejsningsvarianter med ikke-kanoniske biologiske aktiviteter
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
US8815779B2
(en)
|
2009-09-16 |
2014-08-26 |
SwitchGear Genomics, Inc. |
Transcription biomarkers of biological responses and methods
|
CN103724432B
(zh)
|
2009-11-30 |
2016-06-08 |
霍夫曼-拉罗奇有限公司 |
治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
|
EP2509625B1
(de)
|
2009-12-11 |
2015-01-28 |
Atyr Pharma, Inc. |
Histidyl trna-synthetasen zur entzündungshemmung
|
CN103096909A
(zh)
|
2010-05-04 |
2013-05-08 |
Atyr医药公司 |
与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
JP6177129B2
(ja)
|
2010-07-12 |
2017-08-09 |
エータイアー ファーマ, インコーポレイテッド |
ヒスチジルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
EP2621512B1
(de)
|
2010-10-01 |
2016-04-06 |
NsGene A/S |
Verwendung von meteorin zur behandlung von allodynie, hyperalgesie, spontanen schmerzen und phantomschmerzen
|
KR20140048276A
(ko)
|
2011-07-15 |
2014-04-23 |
온코메드 파마슈티칼스, 인크. |
Rspo 결합제 및 이의 용도
|
JP6145667B2
(ja)
|
2011-09-05 |
2017-06-14 |
ホーバ セラピューティクス アンパルトセルスカブ |
アロディニア、痛覚過敏、自発痛、及び幻痛の治療
|
US8835387B2
(en)
|
2012-02-16 |
2014-09-16 |
Atyr Pharma, Inc. |
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
|
KR20150036603A
(ko)
|
2012-07-13 |
2015-04-07 |
온코메드 파마슈티칼스, 인크. |
Rspo3 결합제 및 그의 용도
|
EP2742935A1
(de)
*
|
2012-12-14 |
2014-06-18 |
Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH |
SERF2 für die Atrophiebehandlung oder Steigerung des Zellwachstums
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
EP2878335B1
(de)
|
2013-11-10 |
2018-01-03 |
Brainsgate Ltd. |
Implantat und implantationssystem für nervenstimulator
|
TW201628648A
(zh)
|
2014-09-16 |
2016-08-16 |
安可美德藥物股份有限公司 |
纖維變性疾病之治療
|
US10271907B2
(en)
|
2015-05-13 |
2019-04-30 |
Brainsgate Ltd. |
Implant and delivery system for neural stimulator
|
EP3548039B1
(de)
|
2016-12-04 |
2023-07-19 |
Alavi Khorassani Moghadam, Marcel Victor |
Ribavirin zur verwendung bei der behandlung einer mitochondriellen erkrankung
|
US10905766B2
(en)
*
|
2017-03-23 |
2021-02-02 |
Oregon State University |
Therapeutic compositions and methods for treatment of muscle wasting diseases
|
CN110494452B
(zh)
|
2017-04-03 |
2023-08-25 |
豪夫迈·罗氏有限公司 |
结合steap-1的抗体
|
WO2018195338A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
CN110910960B
(zh)
*
|
2019-11-30 |
2022-07-08 |
浙江天科高新技术发展有限公司 |
一种鲍曼不动杆菌分子血清型快速分析方法
|
IL303383A
(en)
*
|
2020-12-08 |
2023-08-01 |
Imagine Pharma Llc |
Compositions and methods for treating wounds
|